æéå€ååŒÂ  (ET)CSBR ææ°ååæã®æ±ºç®å ±åæž
çºè¡šæ¥9/10/2026
EPSå®çžŸïŒUSDïŒ--
売äžé«å®çžŸïŒUSDïŒ--
Champions Oncology Incã®æ±ºç®æ¥ã»å ±åæž
ãã®ããŒãžã§ã¯ãææ°ã® Champions Oncology Inc ã®æ±ºç®å ±åæžã次å Champions Oncology Inc ã®æ±ºç®äºå®æ¥ãéå»ã®ããŒã¿ãChampions Oncology Inc ã®æ±ºç®é»è©±äŒè°ãã¥ãŒã¹ãªã©ã詳现㪠Champions Oncology Inc ã®æ±ºç®ããŒã¿ãæäŸããŠããŸãã
CSBR 次åååæã®æ±ºç®çºè¡šæ¥
çºè¡šæ¥--
EPSäºæ³ïŒUSDïŒ--
売äžé«äºæ³ïŒUSDïŒ--
CSBR FY2026 決ç®
EPS (å幎åææ¯)-0.08-124.68%
売äžé« (å幎åææ¯)59.42M4.36%
Champions Oncology IncïŒCSBRïŒã®æ±ºç®å±¥æŽ
| å ¬éæ¥ | 察象æéçµäº | EPS/äºæž¬ | åç/äºæž¬ | EPSãµãã©ã€ãº % | 売äžé«ãµãã©ã€ãº % |
|---|---|---|---|---|---|
| 7/27/2026 | 12/2026 | -0.05/-0.05 | 13.84M/12.89M | 4.12% | 7.36% |
| 3/12/2026 | 09/2026 | -0.02/0.09 | 16.56M/16.61M | -122.32% | -0.33% |
| 12/15/2025 | 06/2026 | 0.02/0.01 | 15.04M/14.04M | 94.30% | 7.07% |
| 9/15/2025 | 03/2026 | -0.03/-0.01 | 13.99M/13.51M | -216.20% | 3.57% |
| 7/23/2025 | 12/2025 | -0.13/-0.20 | 12.36M/12.01M | 33.41% | 2.85% |
| 3/11/2025 | 09/2025 | 0.33/-0.01 | 17.04M/12.93M | 3380.90% | 31.76% |
| 12/16/2024 | 06/2025 | 0.05/0.01 | 13.49M/13.05M | 435.50% | 3.33% |
| 9/11/2024 | 03/2025 | 0.10/-0.03 | 14.06M/13.23M | 421.97% | 6.31% |
Champions Oncology Inc ææ°ã®æ±ºç®é»è©±äŒè°èšé²î
ãã£ã³ããªã³ãºã»ãªã³ã³ããžãŒïŒCSBRïŒ2027幎床第1ååæ決ç®èª¬æäŒïŒå£²äžé«ã¯9%å¢ããµãŒãã¹å©ççã¯51%ã«å°é
ãã£ã³ããªã³ãºã»ãªã³ã³ããžãŒã®2027äŒèšå¹ŽåºŠç¬¬1ååæã®å£²äžé«ã¯9%å¢ã®1,520äžãã«ãšãªãã調æŽåŸEBITDAã¯67äž1,000ãã«ã«éãããªã³ã³ããžãŒã»ãµãŒãã¹ã®ããŒãžã³ã¯51%ã«æ¹åããã